Atara Biotherapeutics Inc.
ATRA | NASDAQ
$8.01
-$0.52 (-6.10%)
At close: Oct 30, 2026, 4:00 PM ET
$8.01
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 8:54 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -4.83M | -4.14M | -3.41M | -4.3M | 2.39M | 38.01M | -12.69M | -21.91M | -19.05M | -31.75M | -60.45M | -69.8M | -71.11M | -74.77M | -74.57M | -84.09M | 18.47M | -88.11M | -93.35M | -84.66M | -83.79M | -78.34M |
Depreciation & Amortization | -15K | 29K | 49K | 36K | 236K | 1.8M | 1.1M | 1.23M | 1.33M | 1.39M | 1.21M | 1.21M | 1.2M | 1.21M | 1.26M | 1.37M | 1.44M | 1.59M | 2.49M | 2.32M | 2.32M | 2.22M |
Stock-Based Compensation | 394K | 749K | 1.52M | 1.23M | 2.8M | 4.21M | 5.85M | 6.42M | 6.34M | 8.4M | 9.93M | 11.14M | 12.55M | 11.76M | 11.36M | 14.02M | 14.12M | 14.34M | 14.03M | 13.76M | 13.81M | 12.27M |
Other Working Capital | 833K | -2.52M | -2.44M | -4.98M | -21.56M | -82.39M | -24.32M | 3.82M | -36.53M | -2.8M | 32.59M | -2.1M | 4.62M | -14.63M | 46.56M | 1.7M | -52.06M | -9.21M | 41.96M | 4.31M | 785K | -3.8M |
Other Non-Cash Items | 415K | 1.05M | -1.88M | 1.13M | 29K | 9.96M | 3.68M | 3.71M | 4.12M | 4.09M | 6.19M | 4.13M | 3.47M | 3.81M | 2.94M | 2.94M | -47.16M | 1.13M | 1.24M | 941K | 895K | 754K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 702K | -754K | -1.97M | -7.88M | -12.77M | -82.11M | -22.41M | 6.56M | -3.38M | -11.73M | -7.28M | 1.97M | 1.09M | 19.55M | 2.14M | 707K | -50.83M | -13.48M | 41.33M | 8.67M | 5.2M | -2.61M |
Operating Cash Flow | -3.34M | -3.07M | -5.7M | -9.79M | -7.32M | -28.14M | -24.47M | -3.99M | -10.65M | -29.61M | -50.41M | -51.35M | -52.8M | -38.43M | -56.88M | -65.06M | -63.96M | -84.53M | -34.27M | -58.98M | -61.58M | -65.7M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | -90K | n/a | -29K | -127K | -44K | -281K | -499K | -399K | -37K | -132K | -1.42M | -2.61M | -2.47M | -3.86M | -2.06M | -2.2M |
Cash Acquisitions | n/a | n/a | n/a | 44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -6.63M | n/a | n/a | -2.47M | n/a | n/a | n/a | -19.67M | n/a | n/a | -1K | n/a | -15.74M | -67.9M | 575K | -16.07M | -138.66M | -26.43M | -76.38M | -65.89M | -64.81M | -94.06M |
Sales Maturities Of Investments | n/a | n/a | 7.89M | 1K | n/a | 17.2M | 3.47M | 3M | 7.23M | 14.84M | 9.99M | 70.7M | 65.73M | 62.3M | 50.68M | 75.9M | 77.14M | 89.25M | 54.52M | 70.94M | 98.76M | 109.75M |
Other Investing Acitivies | n/a | n/a | 555K | n/a | -5.42M | n/a | n/a | n/a | n/a | n/a | n/a | 25K | n/a | n/a | n/a | n/a | 94.77M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -6.63M | n/a | 8.44M | -2.42M | -5.07M | 17.2M | 3.38M | -16.67M | 7.2M | 14.72M | 9.94M | 70.45M | 49.48M | -6.01M | 51.22M | 59.7M | 31.83M | 60.22M | -24.32M | 1.19M | 31.89M | 13.5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -250K | -235K | -197K | -233K | -227K | -215K | -208K | -212K | -312K | -122K | -206K | -126K | -64K | -62K | -62K | -64K | -66K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -13K | 12K | n/a | n/a | 117K | -14.82M | 14.94M | -6K | 181K | n/a | 733K | -93K | 432K | -8K | 1.31M | -624K | 1.57M | 842K | 2.59M | 501K |
Financial Cash Flow | 4.83M | 2.95M | -3K | 1.05M | 15.3M | -250K | -328K | 35.79M | -324K | 24.14M | 1.51M | -208K | 471K | 235K | 32.29M | -214K | 1.16M | 19.85M | 51.47M | 47.14M | 2.45M | 2.89M |
Net Cash Flow | -5.14M | -122K | 2.74M | -11.16M | 2.92M | -11.19M | -21.42M | 15.14M | -3.77M | 9.25M | -38.95M | 18.89M | -2.84M | -44.2M | 26.63M | -5.57M | -30.98M | -4.46M | -7.13M | -10.65M | -27.24M | -49.31M |
Free Cash Flow | -3.34M | -3.07M | -5.7M | -9.79M | -7.32M | -28.14M | -24.56M | -3.99M | -10.67M | -29.74M | -50.45M | -51.63M | -53.3M | -38.83M | -56.92M | -65.19M | -65.38M | -87.13M | -36.74M | -62.83M | -63.64M | -67.9M |
Adj. Free Cash Flow | -3.73M | -3.82M | -7.21M | -11.01M | -10.12M | -32.35M | -30.41M | -10.41M | -17.01M | -38.14M | -60.38M | -62.77M | -65.85M | -50.59M | -68.28M | -79.21M | -79.5M | -101.47M | -50.76M | -76.6M | -77.45M | -80.16M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -281K | -499K | -399K | -37K | -132K | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -90K | n/a | -29K | -127K | -44K | n/a | n/a | n/a | n/a | n/a | -1.42M | -2.61M | -2.47M | -3.86M | -2.06M | -2.2M |
Owner Earnings | -3.34M | -3.07M | -5.7M | -9.79M | -7.32M | -28.14M | -24.47M | -3.99M | -10.65M | -29.61M | -50.41M | -51.63M | -53.3M | -38.83M | -56.92M | -65.19M | -63.96M | -84.53M | -34.27M | -58.98M | -61.58M | -65.7M |
Add to Watchlist
Select watchlists to add or remove ATRA